title: An assessment of biologically-based optimization (BORT) in the IMRT era.
abstract: The purpose of this study was to investigate the role of biological-based IMRT (BORT) in treatment planning development; more specifically, to assess the possible advantages of BORT over the classic 3-dimensional conformal radiation therapy (3DRT) and dose-based IMRT based on quantitative and qualitative indices. Three clinical cases are presented to evaluate the differences of BORT, IMRT, and 3DRT. 3DRT, IMRT, and BORT plans were generated for each case using a commercially available treatment planning system (Pinnacle by Philips). The plans were compared by evaluating biological endpoints such as tumor control probability (TCP), normal tissue control probability (NTCP), and uncomplicated tumor control probability (P+), as well as isodose line distribution, dose-volume histograms (DVHs), and dose uniformity. In all cases of this study, BORT yielded improved isodose coverage and P+. Our preliminary results suggest that BORT could play an important role in treatment planning optimization, especially as biological models and predictive assays become more accurate. Further case studies are needed to establish a definitive role for this type of optimization.
authors.affiliation: Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. PenagaricanoJoseA@UAMS.edu
authors.forename: José A
authors.initials: JA
authors.lastname: Peñagarícano
authors.forename: Nikos
authors.initials: N
authors.lastname: Papanikolaou
authors.forename: Chuan
authors.initials: C
authors.lastname: Wu
authors.forename: Yulong
authors.initials: Y
authors.lastname: Yan
mesh_terms: D001932:Brain Neoplasms / Q000532:radiotherapy*; D006528:Carcinoma, Hepatocellular / Q000532:radiotherapy*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000532:radiotherapy*; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D008113:Liver Neoplasms / Q000532:radiotherapy*; D009447:Neuroblastoma / Q000532:radiotherapy*; D010255:Paranasal Sinus Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy; D016896:Treatment Outcome